| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/08/2002 | WO2002020762A3 Tnf receptor-like molecules and uses thereof |
| 08/08/2002 | WO2002014366A3 Genes involved in immune related responses observed with asthma |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2002000194A3 Polymeric micelle compositions |
| 08/08/2002 | WO2001098522A3 Positively-charged peptide nucleic acid analogs with improved properties |
| 08/08/2002 | WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 08/08/2002 | WO2001096379A3 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
| 08/08/2002 | WO2001092547A3 Modified bovine adenovirus having altered tropism |
| 08/08/2002 | WO2001092306A3 Therapeutic compounds for ovarian cancer |
| 08/08/2002 | WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 08/08/2002 | WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
| 08/08/2002 | WO2001085784A9 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001079274B1 Tuberculosis antigens and methods of use thereof |
| 08/08/2002 | WO2001077376A3 Diagnosis of diseases associated with metastasis |
| 08/08/2002 | WO2001076451A9 Diagnosis of diseases associated with metabolism |
| 08/08/2002 | WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 08/08/2002 | WO2001068116A3 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections |
| 08/08/2002 | WO2001059152A9 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/08/2002 | WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/08/2002 | WO2001032925A9 Modulation of neuroendocrine differentiation by protein 25.1 |
| 08/08/2002 | WO2001029062A9 Method for modulation of cell phenotype |
| 08/08/2002 | WO2001023604A3 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 08/08/2002 | WO2001021799A9 Traf4 associated cell cycle proteins, compositions and methods of use |
| 08/08/2002 | WO2001016330A3 Prevention of affections associated with porcine circovirus-2 |
| 08/08/2002 | WO2001013714A3 Prostatic cell line and animal model of a prostatic tumor |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | WO2001009325A9 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/08/2002 | WO2000074635A3 Delivery of single stranded dna for expression |
| 08/08/2002 | US20020108136 Animal models for use as tools in the treatment of genetic disorders |
| 08/08/2002 | US20020108133 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 08/08/2002 | US20020107869 Novel implant and novel vector for the treatment of acquired diseases |
| 08/08/2002 | US20020107385 Human breast tumor-specific proteins |
| 08/08/2002 | US20020107376 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of liver disorders and cancer |
| 08/08/2002 | US20020107375 Novel human lipocalin homologs and polynucleotides encoding the same |
| 08/08/2002 | US20020107372 Nucleotide sequences coding membrane protein for use in the treatment of inflammation,lung defects and viral diseases |
| 08/08/2002 | US20020107368 Helicobacter proteins, gene sequences and uses thereof |
| 08/08/2002 | US20020107365 Ligands for flt3 receptors |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107360 Hepatitis E virus antigens and uses therefor |
| 08/08/2002 | US20020107330 Drug delivery compositions and medical devices containing block copolymer |
| 08/08/2002 | US20020107220 By replication of the nucleic acids of the viruses in that distribution by use of a defective replication system; virus population lose pathogenic properties, infectiousness; treating viral diseases |
| 08/08/2002 | US20020107219 Adenoviral vector containing cyclooxygenase-2 promoter and uses thereof |
| 08/08/2002 | US20020107218 Using inhibitors such as antisense nucleic acids |
| 08/08/2002 | US20020107215 Nucleic acids and proteins that are markers for specific normal or cancerous tissues; use in diagnosis of cancer; gene expression using specified tissue-specific promoters |
| 08/08/2002 | US20020107214 Using chimeric restriction endonucleases; treating or prophylaxis of a genetic disease |
| 08/08/2002 | US20020107213 Gene therapy of alzheimer's disease by delivery of an encoded apoliprotein E |
| 08/08/2002 | US20020107211 Ob polypeptides; treating obesity; antagonists thereof to increase weight |
| 08/08/2002 | US20020107210 Compositions and methods for the treatment of autoimmune diabetes |
| 08/08/2002 | US20020107206 Treatment of acute coronary syndrome with GLP-1 |
| 08/08/2002 | US20020107198 Includes glucose response element (GIRE) of a liver-pyruvate (L-PK) gene promoter, and insulin-sensitive element of an insulin-like growth factor binding protein-1 (IGFBP-1) basal promoter; stimulated by glucose and inhibited by insulin |
| 08/08/2002 | US20020107194 Able to bind to a Notch protein forming Delta-Notch complex |
| 08/08/2002 | US20020107192 Isolated 23686 proteins, fusion proteins, antigenic peptides and anti-23686 antibodies and diagnostic methods utilizing said |
| 08/08/2002 | US20020107189 FK506 binding proteins (FKBPs); rapamysin derivatives; multimerizing chimeric proteins in genetically engineered cells using said derivatives |
| 08/08/2002 | US20020107171 Regulation of the P21 gene and uses thereof |
| 08/08/2002 | US20020107170 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 08/08/2002 | US20020106799 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 08/08/2002 | US20020106798 Plasmid for use in vaccination of animals aganist fungal, bacterial and viral infections |
| 08/08/2002 | US20020106795 Pluripotent stem cell; for use in the treatment of thalassemia and sickle cell anemia |
| 08/08/2002 | US20020106794 Purifying dopamine cells; obtain cells, transfect with vector coding fluorescent molecules, detect fluorescent cells, recover fluorscent cells |
| 08/08/2002 | US20020106790 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells |
| 08/08/2002 | US20020106789 A Polynucleotide |
| 08/08/2002 | US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 08/08/2002 | US20020106778 Human PTTG polypeptide and method for producing it |
| 08/08/2002 | US20020106776 pth |
| 08/08/2002 | US20020106774 Nucleotide sequences coding enzymatic polypeptide for use in treatment and diagnosis of cell proliferative and/ differentiative, bone, immune, hematopoietic, cardiovascular disorders and liver disorders viral diseases and pain |
| 08/08/2002 | US20020106772 Geranyl diphosphate synthase large subunit, and methods of use |
| 08/08/2002 | US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects |
| 08/08/2002 | US20020106742 Nucleic acids encoding active and inactive CCR5 chemokine receptors |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects |
| 08/08/2002 | US20020106729 Nucleotide sequences for use as tools in genetic engineering |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106724 RNA-binding protein |
| 08/08/2002 | US20020106713 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule |
| 08/08/2002 | US20020106689 Detecting immunological defects in mammal; obtain sample tissue from mammal, detect proteasome activity, reduction in proteasome activty indicates immunological defect |
| 08/08/2002 | US20020106671 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 08/08/2002 | US20020106645 Detecting preferential psychological disorders; obtain tissue sample, detect sequences polymorphism, presence of polymorphism indicates psychological disorders |
| 08/08/2002 | US20020106635 Cytokine resistant cytomegalovirus promoter mutants and related products and methods |
| 08/08/2002 | US20020106631 Recombinant, active caspases and uses thereof |
| 08/08/2002 | US20020106382 Modified adenovirus and uses thereof |
| 08/08/2002 | US20020106381 Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus |
| 08/08/2002 | US20020106356 Secreted proteins |
| 08/08/2002 | US20020106350 Methods for therapy of neurodegenerative disease of the brain |
| 08/08/2002 | US20020106349 Dilute viral suspension is prepared corresponding to the dilution of a viral suspension in an aqueous solution containing salt or hexose; dilute viral suspension is nebulized pressurized gas of or an ultrasound frequency |
| 08/08/2002 | US20020106330 Sdministering aerosolized drug in an air mixture containing up to about 10% carbon dioxide gas for increasing the deposition of aerosolized drug in the respiratory tract of an individual or animal |
| 08/08/2002 | US20020106324 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family |
| 08/08/2002 | CA2437555A1 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | CA2437021A1 Adiponectin-associated protein |
| 08/08/2002 | CA2436661A1 Novel nucleic acid and polypeptide molecules |
| 08/08/2002 | CA2434097A1 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2430921A1 Use of a vector encoding a ghrh peptide to enhance growth in multiple litters of offspring from female animals |
| 08/08/2002 | CA2430653A1 Transfection of human embryonic stem cells |
| 08/08/2002 | CA2427143A1 Compositions and methods for improving kidney function |
| 08/08/2002 | CA2426582A1 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/07/2002 | EP1229124A1 Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 08/07/2002 | EP1229113A2 Recombinational cloning using engineered recombination sites |
| 08/07/2002 | EP1229045A1 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 08/07/2002 | EP1229043A1 Peptides derived from Epstein Barr virus (EBV) proteins LMP1, LMP2 and BARF1 antibody reagents reactive therewith |